1181 related articles for article (PubMed ID: 34506535)
21. Sex hormonal factors and chronic widespread pain: a population study among women.
Macfarlane TV; Blinkhorn A; Worthington HV; Davies RM; Macfarlane GJ
Rheumatology (Oxford); 2002 Apr; 41(4):454-7. PubMed ID: 11961178
[TBL] [Abstract][Full Text] [Related]
22. Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women.
Amigoni S; Morelli P; Chatenoud L; Parazzini F
Climacteric; 2000 Mar; 3(1):25-32. PubMed ID: 11910606
[TBL] [Abstract][Full Text] [Related]
23. Why do women doctors in the UK take hormone replacement therapy?
Isaacs AJ; Britton AR; McPherson K
J Epidemiol Community Health; 1997 Aug; 51(4):373-7. PubMed ID: 9328541
[TBL] [Abstract][Full Text] [Related]
24. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
[TBL] [Abstract][Full Text] [Related]
25. Menopausal symptoms and attitudes toward hormone replacement therapy among Israeli women.
Frankenthal D; Karni-Efrati Z; Zatlawi M; Keinan-Boker L; Bromberg M
J Women Aging; 2024; 36(1):1-13. PubMed ID: 37319035
[TBL] [Abstract][Full Text] [Related]
26. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular disease in women and noncontraceptive use of hormones: a feminist analysis.
MacPherson KI
ANS Adv Nurs Sci; 1992 Jun; 14(4):34-49. PubMed ID: 1605587
[TBL] [Abstract][Full Text] [Related]
28. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
[TBL] [Abstract][Full Text] [Related]
29. Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density.
Cartwright B; Robinson J; Seed PT; Fogelman I; Rymer J
J Clin Endocrinol Metab; 2016 Sep; 101(9):3497-505. PubMed ID: 27340881
[TBL] [Abstract][Full Text] [Related]
30. Myocardial infarction risk and hormone replacement: differences between products.
de Vries CS; Bromley SE; Farmer RD
Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
[TBL] [Abstract][Full Text] [Related]
31. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
Vessey MP
Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
[TBL] [Abstract][Full Text] [Related]
32. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
Perrone G; Capri O; Borrello M; Galoppi P
Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
[TBL] [Abstract][Full Text] [Related]
33. Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy.
Lee AJ; Lowe GD; Smith WC; Tunstall-Pedoe H
Br J Haematol; 1993 Apr; 83(4):616-21. PubMed ID: 8518178
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of exogenous estrogen versus a estrogen-progesterone combination on auditory evoked potentials in menopausal women.
Khaliq F; Tandon OP; Goel N
Indian J Physiol Pharmacol; 2005; 49(3):345-52. PubMed ID: 16440855
[TBL] [Abstract][Full Text] [Related]
35. The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva.
Yalçin F; Gurgan S; Gurgan T
J Contemp Dent Pract; 2005 May; 6(2):10-7. PubMed ID: 15915200
[TBL] [Abstract][Full Text] [Related]
36. [Influence of the presence of hot flashes during menopause on the metabolism of nitric oxide. Effects of hormonal replacement treatment].
Leal Hernández M; Abellán Alemán J; Carbonell Meseguer LF; Díaz Fernández J; García Sánchez FA; Martínez Selva JM
Med Clin (Barc); 2000 Jan; 114(2):41-5. PubMed ID: 10702946
[TBL] [Abstract][Full Text] [Related]
37. Plasma fibrinogen: its relationship with oral contraception, the menopause, and hormone replacement therapy.
Lee AJ; Lowe GD; Smith WC; Tunstall-Pedoe H
Clin Biochem; 1992 Oct; 25(5):403-5. PubMed ID: 1490307
[TBL] [Abstract][Full Text] [Related]
38. An estrogen model: the relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk.
Green LE; Dinh TA; Smith RA
Comput Math Methods Med; 2012; 2012():792375. PubMed ID: 22291855
[TBL] [Abstract][Full Text] [Related]
39. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
[TBL] [Abstract][Full Text] [Related]
40. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
